This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Carboplatin and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (2788)
Death (558)
Life Threatening Events (220)
Disability (62)
Reports by Reaction Type
Vomiting (245),
Nausea (244),
Diarrhoea (237),
Anaemia (233),
Neutropenia (217),
Febrile Neutropenia (206),
Dyspnoea (202),
Dehydration (166),
Fatigue (165),
Pyrexia (141),
Thrombocytopenia (125),
Neutrophil Count Decreased (125)
Below are a few examples of reports where side effects / adverse reactions may be related to Carboplatin. For a complete list or a specific selection of reports, please use the links above.
Possible Carboplatin side effects in 68 year old male
Reported by a physician from United States on 2012-08-27
Patient: 68 year old male, weighing 74.5 kg (163.9 pounds)
Reactions: Lobar Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arixtra
Indication: Venous Thrombosis
Start date: 2012-07-18
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-27
Taxol
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-27
Possible Carboplatin side effects in male
Reported by a physician from United States on 2012-08-27
Patient: male, weighing 99.9 kg (219.7 pounds)
Reactions: Failure To Thrive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: Salivary Gland Cancer
OGX-011
Start date: 2012-08-08
End date: 2012-08-08
OGX-011
Start date: 2012-08-10
End date: 2012-08-10
OGX-011
Indication: Salivary Gland Cancer
Start date: 2012-08-06
End date: 2012-08-06
Paclitaxel
Indication: Salivary Gland Cancer
Other drugs received by patient: Oxycodone HCL; Duragesic-12; Atenolol; Tamsulosin HCL; Gabapentin; Finasteride
Possible Carboplatin side effects in male
Reported by a physician from United Kingdom on 2012-08-27
Patient: male, weighing 77.5 kg (170.5 pounds)
Reactions: Supraventricular Tachycardia
Drug(s) suspected as cause:
Carboplatin
Dosage: 300 mg, 30 min iv infusion, on day 1 of each 21 day cycle
Indication: Transitional Cell Carcinoma
Start date: 2012-06-22
End date: 2012-07-11
Gemcitabine Hydrochloride
Dosage: 1900 mg, 30 min iv infusion, on day 1 and 8 of each 21 day cycle
Indication: Transitional Cell Carcinoma
Start date: 2012-06-22
End date: 2012-07-19
Zd6474
Administration route: Oral
Indication: Transitional Cell Carcinoma
Start date: 2012-06-22
End date: 2012-08-01
Other drugs received by patient: Lactulose; Tinzaparin; Acetaminophen and Codeine Phosphate; Acetaminophen and Codeine Phosphate
Possible Carboplatin side effects in male
Reported by a physician from France on 2012-08-27
Patient: male
Reactions: Malaise, Cyanosis, Formication
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 415mg cyclic
Indication: Lung Neoplasm Malignant
Start date: 2012-06-20
End date: 2012-06-20
Methylprednisolone
Dosage: 40mg single dose
Indication: Premedication
Start date: 2012-06-20
End date: 2012-06-20
Plitican
Dosage: 150mg single dose
Indication: Premedication
Start date: 2012-06-20
End date: 2012-06-20
Zofran
Dosage: 8mg single dose
Indication: Premedication
Start date: 2012-06-20
End date: 2012-06-20
Other drugs received by patient: Vinorelbine
Possible Carboplatin side effects in 72 year old female
Reported by a physician from United States on 2012-08-27
Patient: 72 year old female, weighing 71.6 kg (157.5 pounds)
Reactions: Ventricular Arrhythmia
Drug(s) suspected as cause:
Avastin
Dosage: 15 mg/kg iv over 30-90 minutes on day 1 on 2 cycle onwards
Indication: Ovarian Epithelial Cancer
Carboplatin
Dosage: auc 6 (cycle 1-6),6th cycle completed on 16/feb/2012
Indication: Ovarian Epithelial Cancer
Start date: 2011-11-23
Ipratropium Bromide
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 175 mg/m2 over 3 hrs on day 1(cycle 1-6), 6th cycle completed on 16/feb/2012
Indication: Ovarian Epithelial Cancer
Start date: 2011-11-23
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-08-27
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bacteraemia, Hypovolaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 5 df, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-07
End date: 2012-06-26
Gemcitabine Hydrochloride
Dosage: 1000 mg/m2, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-07
End date: 2012-07-02
Other drugs received by patient: Prednisone TAB; Clonidine; Guaifenesin; Albuterol Sulfate; Calcium; Methimazole; Potassium Chloride; Aspirin; Leflunomide
Possible Carboplatin side effects in
Reported by a physician from Netherlands on 2012-08-27
Patient:
Reactions: Disease Progression
Drug(s) suspected as cause:
Avastin
Indication: non-Small Cell Lung Cancer
Carboplatin
Indication: non-Small Cell Lung Cancer
Pemetrexed
Indication: non-Small Cell Lung Cancer
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Off Label Use, Gastrointestinal Toxicity, Neutropenia, Infection
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Cyclophosphamide
Indication: Retinoblastoma
Doxorubicin Hydrochloride
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Etoposide
Indication: Retinoblastoma
Vincristine
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Other drugs received by patient: Neupogen
Possible Carboplatin side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-27
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Carboplatin
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cisplatin
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cytarabine
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dacarbazine
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dexamethasone Sodium Phosphate
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin HCL
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin HCL
Dosage: unk
Indication: Hodgkin's Disease
Etoposide
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Etoposide
Dosage: unk
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Gemcitabine Hydrochloride
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Ifosfamide
Dosage: unk
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Rituximab
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Vinblastine
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Vinorelbine
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Possible Carboplatin side effects in female
Reported by a physician from Germany on 2012-08-27
Patient: female, weighing 72.0 kg (158.4 pounds)
Reactions: Stomatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Start date: 2012-05-16
Carboplatin
Indication: Breast Cancer
Start date: 2012-03-15
End date: 2012-05-02
Doxorubicin Hydrochloride
Indication: Breast Cancer
Start date: 2012-03-15
End date: 2012-05-02
Doxorubicin Hydrochloride
Dosage: 4.7143 milligram daily;
Start date: 2012-05-16
Lapatinib
Dosage: 750 milligram daily;
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-15
Paclitaxel
Indication: Breast Cancer
Start date: 2012-03-15
End date: 2012-05-02
Paclitaxel
Dosage: 11.4286 mg/m2 daily;
Start date: 2012-05-16
Trastuzumab
Indication: Breast Cancer
Start date: 2012-03-15
End date: 2012-04-25
Other drugs received by patient: Granocyte; Ciprofloxacin HCL
Possible Carboplatin side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Ireland on 2012-08-24
Patient: 67 year old female
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded: Ipilimumab
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-22
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-10
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2012-04-10
Placebo
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-22
Other drugs received by patient: Miralax; Multi-Vitamin; Coumadin; Diphenhydramine Hydrochloride; Dexamethasone; Advair Diskus 100 / 50; Prednisone TAB; Spiriva; Magnesium Oxide; Potassium Chloride; Tramadol HCL; Calcium Carbonate; Coumadin; Omeprazole; Pristiq; Proair HFA
Possible Carboplatin side effects in 74 year old male
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: 74 year old male, weighing 102.0 kg (224.4 pounds)
Reactions: Chronic Obstructive Pulmonary Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: last dose: 02aug12
Indication: Bronchioloalveolar Carcinoma
Start date: 2012-05-30
Carboplatin
Dosage: last dose: 02aug12
Indication: Bronchioloalveolar Carcinoma
Start date: 2012-05-30
Paclitaxel
Dosage: last dose: 02aug12
Indication: Bronchioloalveolar Carcinoma
Start date: 2012-05-30
Possible Carboplatin side effects in female
Reported by a pharmacist from United States on 2012-08-24
Patient: female, weighing 139.7 kg (307.3 pounds)
Reactions: Glossodynia, Unresponsive To Stimuli, Hypoxia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Carboplatin
Other drugs received by patient: Lorazepam; Warfarin Sodium; Nifedipine; Citalopram Hydrobromide; Fiornal; Joint Food; Tylox; Losartan Potassium; Omeprazole; Paclitaxel; Calcium D3; Dexamethasone
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)
Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 30 mg/m2 x 1/4 week
Start date: 2011-03-16
Adriamycin PFS
Dosage: 40 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Carboplatin
Dosage: 250 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Cyclophosphamide
Dosage: 350 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Etoposide
Dosage: 100 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Prednisolone
Dosage: 1mg/kg x 1/2 week
Start date: 2011-12-13
End date: 2011-12-14
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Start date: 2011-03-16
Prednisolone
Dosage: 2 mg/m2, 1x/day
Administration route: Oral
Start date: 2011-03-24
Ranimustine
Dosage: 60 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-16
Vincristine Sulfate
Dosage: 1 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Vindesine Sulfate
Dosage: 2.4 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium
Possible Carboplatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-24
Patient: female
Reactions: Urticaria, Bronchospasm, Laryngeal Oedema, Muscle Rigidity
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in male
Reported by a physician from France on 2012-08-24
Patient: male
Reactions: Dermatitis Acneiform, Renal Failure, Neoplasm Malignant, Dehydration, Purpura, Neutropenia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Dosage: 200 df, unknown/d
Indication: non-Small Cell Lung Cancer
Start date: 2012-08-03
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Start date: 2012-08-17
Pemetrexed Disodium
Dosage: 200 df, unknown/d
Indication: non-Small Cell Lung Cancer
Start date: 2012-08-03
Possible Carboplatin side effects in female
Reported by a physician from Ireland on 2012-08-24
Patient: female, weighing 75.5 kg (166.1 pounds)
Reactions: Vomiting, Diarrhoea, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 790mg cyclic
Indication: Breast Cancer
Start date: 2012-08-09
Docetaxel
Dosage: 75mgm2 cyclic
Indication: Breast Cancer
Start date: 2012-08-09
Lapatinib
Dosage: 1000mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-08-09
Trastuzumab
Dosage: 8mgk cyclic
Indication: Breast Cancer
Start date: 2012-08-09
Possible Carboplatin side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-24
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Neoplasm Malignant, Cytomegalovirus Infection, Pancytopenia, Immunosuppression
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Start date: 2006-01-01
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cytarabine
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dacarbazine
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Start date: 2006-01-01
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Start date: 2006-01-01
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Dexamethasone
Possible Carboplatin side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: 65 year old male, weighing 83.0 kg (182.6 pounds)
Reactions: White Blood Cell Count Decreased, Platelet Count Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 135mg/m2/auc 4
Indication: Ovarian Cancer
Start date: 2012-08-13
End date: 2012-08-13
Paclitaxel
Indication: Ovarian Cancer
Start date: 2012-08-13
End date: 2012-08-17
Ridaforolimus
Dosage: 10mg po day 1-5
Administration route: Oral
Possible Carboplatin side effects in 58 year old male
Reported by a consumer/non-health professional from Argentina on 2012-08-24
Patient: 58 year old male
Reactions: Hepatotoxicity, Neoplasm Malignant, Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Start date: 2012-01-01
Yervoy
Dosage: no of inf:2 infusion on 9feb12
Indication: Metastatic Malignant Melanoma
Start date: 2012-02-09
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: , weighing 1.9 kg (4.1 pounds)
Reactions: Foetal Growth Restriction, Foetal Exposure During Pregnancy
Drug(s) suspected as cause:
Carboplatin
Indication: Ovarian Cancer Stage I
Paclitaxel
Indication: Ovarian Cancer Stage I
Possible Carboplatin side effects in female
Reported by a physician from Germany on 2012-08-23
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 5 auc
Indication: Breast Cancer
Start date: 2012-04-25
Docetaxel
Indication: Breast Cancer
Start date: 2012-04-25
Herceptin
Indication: Breast Cancer
Start date: 2012-04-25
Herceptin
Placebo
Indication: Breast Cancer
Start date: 2012-04-25
Other drugs received by patient: Metoprolol Tartrate
Possible Carboplatin side effects in 70 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient: 70 year old male
Reactions: Blood Pressure Increased, Wheezing, Heart Rate Increased, Erythema, Hyperhidrosis, Cough
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in 59 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23
Patient: 59 year old female
Reactions: Encephalopathy
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Carboplatin
Start date: 2012-07-20
End date: 2012-07-20
Etoposide
Start date: 2012-07-19
End date: 2012-07-21
Ifosfamide
Start date: 2012-07-20
End date: 2012-07-21
Mabthera
Start date: 2012-07-19
End date: 2012-07-19
Mesna
Start date: 2012-07-20
End date: 2012-07-21
Other drugs received by patient: Solu-Medrol; Acetaminophen; Polaramine
Possible Carboplatin side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-23
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-08-23
Patient: female, weighing 81.1 kg (178.5 pounds)
Reactions: Anaemia, Lymphocyte Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 625 mg
Taxol
Dosage: 320 mg
Possible Carboplatin side effects in 68 year old male
Reported by a physician from United States on 2012-08-23
Patient: 68 year old male, weighing 74.5 kg (163.9 pounds)
Reactions: Lobar Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arixtra
Indication: Venous Thrombosis
Carboplatin
Indication: non-Small Cell Lung Cancer
Taxol
Indication: non-Small Cell Lung Cancer
Possible Carboplatin side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-23
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-08-23
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: Weight Decreased, Escherichia Test Positive, Malaise, Vomiting, Nausea, Dysuria, Clostridium Difficile Colitis, Culture Urine Positive, Thrombocytopenia, Enterobacter Test Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 376 mg
Taxol
Dosage: 299 mg
Possible Carboplatin side effects in female
Reported by a physician from Germany on 2012-08-23
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: Breast Cancer
Start date: 2012-06-15
Lapatinib
Dosage: 750mg per day
Indication: Breast Cancer
Start date: 2012-06-15
Liposome Encapsulated Doxorubicin Citrate Complex
Dosage: 20mgm2 weekly
Indication: Breast Cancer
Start date: 2012-06-15
Paclitaxel
Dosage: 80mgm2 weekly
Indication: Breast Cancer
Start date: 2012-06-15
Trastuzumab
Dosage: 6mgk every 3 weeks
Indication: Breast Cancer
Start date: 2012-06-15
Other drugs received by patient: Loperamide; Neupogen
|